Irrimax Corporation actively invests in a research program designed to support existing products and to identify new methods to help treat and prevent infections, reduce healthcare costs, improve patient outcomes and safety of healthcare professionals.
Research methodologies include the use of laboratory studies, case studies, and research use only programs. We are committed to sharing our clinical data with the medical community, patients, the media, policy makers and the public.
For more information about our research program, please contact Customer Service who will put in touch with the appropriate clinical team member cs@irrisept.com
Share:
© 2022 Irrimax Corporation. All Rights Reserved.
Irrimax®, Irrisept®, Irririnse®, Irriprobe® and Splatterguard® (all regardless of letter case) are registered trademarks of Innovation Technologies, Inc., parent company of Irrimax Corporation.
